Regulation of Calcium and Phosphate Homeostasis II Flashcards
E2 and the anabolic androgens (testosterone and dihydrotestosterone) stimulate bone growth and increase and/or maintain
Bone density
Exerts a number of effects that collectively affect Ca2+ and PO4 homeostasis to maintain bone density
Estrogen
Stimulates the expression of VDR in the duodenum and may also directly increase Ca2+ absorption
E2
What is the predominant ER receptor in humans?
ER-alpha
Estrogen receptors are expressed by
Growth plate chondrocytes
Acts in a biphasic manner to first stimulate longitudinal bone growth, but then over time induces epiphyseal closure, thus terminating longitudinal growth
ER
In osteocytes, E2 blocks apoptosis and stimulates the secretion of
TGFB
Blocks osteoclast differentiation
TGFB
Impairs osteoclast differentiation and RANKL synthesis
Estrogen
Which three things does estrogen promote in bones?
- ) Osteoclast apoptosis
- ) Osteoblast proliferation
- ) Osteoprotegerin production
Collectively, these actions support the maintenance of bone density by thwarting
Osteoclast-mediated reabsorption
Is by and large sequestered to the epiphyseal chondrocytes, growth plate cartilage, osteocytes, and osteoblasts
Androgen Receptor (AR) expression
Men with total E2 deficiency due to mutations in either ERa or CYP19 exhibit severe
-Despite normal testosterone levels
Osteopenia
Thus, we may not receive a direct effect on bone growth from
AR expression
Aromatase, i.e. the enzyme which aromatizes testosterone into E2
CYP19
We can treat these men with osteopenia in order to induce epiphyseal closure and longitudinal bone growth by giving them
Exogenous Estrogen
Since the predominant circulating anabolic androgen, testosterone, can be aromatized into E2 by a variety of tissues, the anabolic effects of androgens in bone are possibly due to
E2
The best indicator of fracture risk in aging men
E2
21-carbon steroids produced by the adrenal cortex
-produced in zona fasciculata and zona reticularis
Glucocorticoids
In the context of bone, function to enhance reabsorption
Glucocorticoids
Thus, prolonged glucocorticoid excess can result in
Glucocorticoid-induced osteoporosis
Glucocorticoid-induced osteoporosis can lead to the development of
Osteonecrosis
The rapid focal deterioration of bone, often occuring within the femoral head
Osteonecrosis
Has complex effects in bone, involving both direct (via effects within osteoblasts, osteoclasts, and osteocytes), as well as indirect mechanisms within the kidneys and the small intestine where Ca2+ reabsorption and absorption, respectively, are impaired
Glucocorticoids
Impede skeletal muscle function by increasing catabolism
Glucocorticoids
Muscle wasting and the deleterious effects within bone can be exacerbated by the inhibitory effect of glucocorticoids on
Gonadal estrogen and androgen production
Osteoblasts, osteoclasts, and osteocytes all express
Glucocorticoid receptors
Within osteoblasts and osteocytes, glucocorticoids upregulate
Apoptosis
Actually extend the life of osteoclasts
Glucocorticoids
The production of RANKL is promoted by
Glucocorticoids
The production of RANKL is promoted by glucocorticoids, thereby increasing the ratio of
RANKL:osteoprotegerin; a mechanism that promotes
Osteoclast-mediated bone reabsorption
Predominantly synthesized by the liver in response to GH
IGF-I
However, it has been shown that IGF-I is also synthesized in
Osteocytes and chondrocytes
Postnatally and through adolescence, GH and IGF-1 together stimulate
Longitudinal bone growth
In long bones, exerts mitogenic effects in chondrocytes within the epiphyseal cartilages (epiphyseal lengthening) concomitant with stimulating local IGF-1 expression
GH
Due to their anabolic effects, GH and IGF-I can also regulate modeling and remodeling of
Trabecular and cortical bone
Note that the anabolic effects of GH depend on
IGF-I
Osteoblast activity is upregulated by
GH